Search For "mild"
Prescription to sit less, move more advised for mildly high blood pressure
Updated : 4 years, 9 months ago IST
Dallas [US], June 2 (ANI): While a lot of people are suffering from elevated blood pressure and blood cholesterol, a recent study has pointed out a common first treatment choice prescribed by medical practitioners.
Read More
Eli Lilly's antibody cocktail drug gets emergency use nod in India
Updated : 4 years, 9 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 4 years, 9 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
COVID antibody cocktail now offered to patients at Indraprastha Apollo Hos
Updated : 4 years, 9 months ago IST
New Delhi [India], May 28 (ANI): Roche India's Antibody Cocktail (Casirivimab and Imdevimab) is now available as a therapy to treat patients with mild and moderate COVID-19 infection at the Indraprastha Apollo Hospitals in Delhi, the hospital said in a statement on Friday.
Read More
Hyderabad: Mosque converted into 40-bed COVID care centre
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 26 (ANI): In order to deal with the shortage of beds, medical oxygen, and the required medicines in COVID hospitals in the city, a Hyderabad-based NGO came forward and converted a mosque into a COVID Care Centre where mild to moderate patients are being tre
Read More
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Read More
Mild COVID-19 induces lasting antibody protection: Study
Updated : 4 years, 9 months ago IST
Washington [US], May 25 (ANI): Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19. Such cells could persist for a lifetime, churning out antibodies all the while, suggested a new stud
Read More
Delhi HC dismisses PIL seeking direction to ICMR, Niti Ayog regarding modi
Updated : 4 years, 9 months ago IST
New Delhi [India], May 25 (ANI): The Delhi High Court on Tuesday dismissed a Public Interest Litigation (PIL) seeking direction to the Central India, Indian Council of Medical Research (ICMR) and NITI Aayog regarding reconsideration of the prevalent treatment protocol for a mild case of COVI
Read More
SDMC sets up COVID-care centre for children in Delhi school
Updated : 4 years, 9 months ago IST
New Delhi [India], May 24 (ANI): The South Delhi Municipal Corporation (SDMC) has set up a COVID care centre for children at a Municipal Corporation of Delhi (MCD) school to treat COVID-positive children with mild or moderate cases.
Read More
Plea in Delhi HC seeks modification of treatment protocol regarding use of
Updated : 4 years, 9 months ago IST
New Delhi [India], May 24 (ANI): A petition has been moved in the Delhi High Court on Monday that seeks direction to the Union of India, Indian Council of Medical Research (ICMR), and Niti Ayog regarding reconsideration of the prevalent treatment protocol for mild cases of COVID-19, and to a
Read More
Covid Care facility in Hyderabad revamps its infrastructure to treat patie
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 22 (ANI): In order to treat severe and critically ill COVID-19 patients, a Covid Care Centre named 'Project Ashray' in Hyderabad has ramped up its infrastructure to create a 100-bed capacity to treat patients with to moderate coronavirus symptoms.
Read More
Drugs manufacturer from Hyderabad on overdrive
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
Read More